THCbiz

Advertisement

Tue09192017

      Cannabis Industry B2B Directory: Featured Businesses
Back You are here: Home News Industry News FDA Looking Into Rescheduling Marijuana

FDA Looking Into Rescheduling Marijuana


The Food and Drug Administration is considering reclassifying cannabis or de-listing it altogether, which would end the federal ban.

U.S. regulators are studying whether restrictions on marijuana should be eased -- a step toward decriminalizing the drug at the federal level, reports Bloomberg.

The Food and Drug Administration is conducting an analysis at the Drug Enforcement Administration’s request on whether the U.S. should downgrade the classification of marijuana as a Schedule 1 drug, said Douglas Throckmorton, Deputy Director for Regulatory Programs at the FDA, at a congressional hearing.

Schedule 1 drugs carry the most restrictions of the five DEA classifications and are considered substances with no medical benefit that are highly addictive. Factors the FDA considers in making a recommendation include a drug’s abuse potential, its pharmacological effect and risk to public health, according to Throckmorton’s written testimony.

Read the full story 



comments powered by Disqus

Advertisement
Advertisement